Cargando…

Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease

AD is the most common neurodegenerative disorder characterized by progressive memory impairment and cognitive deficits. The pathology of AD is still unclear; however, several studies have shown that the aggregation of the Aβ peptide in the CNS is an exclusively pathological process involved in AD. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharari, Sanaa, Vaikath, Nishant N., Tsakou, Magdalini, Ghanem, Simona S., Vekrellis, Kostas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379574/ https://www.ncbi.nlm.nih.gov/pubmed/37511086 http://dx.doi.org/10.3390/ijms241411326

Ejemplares similares

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
por: Vaikath, Nishant, et al.
Publicado: (2022)

Assessment of Aggregated and Exosome-Associated α-Synuclein in Brain Tissue and Cerebrospinal Fluid Using Specific Immunoassays
por: Anagnostou, Dimitrios, et al.
Publicado: (2023)

Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity
por: Ghanem, Simona S., et al.
Publicado: (2021)

Oxidation destabilizes toxic amyloid beta peptide aggregation
por: Razzokov, J., et al.
Publicado: (2019)

Differential Effects of Endocannabinoids on Amyloid-Beta Aggregation and Toxicity
por: Khavandi, Marzie, et al.
Publicado: (2023)

Allium roseum L. extract inhibits amyloid beta aggregation and toxicity involved in Alzheimer’s disease
por: Boubakri, Abdelbasset, et al.
Publicado: (2020)

Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts
por: Ardah, Mustafa T., et al.
Publicado: (2020)

Phosphorylation of amyloid beta (Aβ) peptides – A trigger for formation of toxic aggregates in Alzheimer's disease
por: Kumar, Sathish, et al.
Publicado: (2011)

In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer’s Disease Treatment
por: Job, Nisha, et al.
Publicado: (2023)

Controlling Amyloid Beta Peptide Aggregation and Toxicity by Protease-Stable Ligands
por: Mallesh, Rathnam, et al.
Publicado: (2023)

Investigating the presence of doubly phosphorylated α‐synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases
por: Fayyad, Muneera, et al.
Publicado: (2020)

Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains
por: Esparza, Thomas J., et al.
Publicado: (2016)

Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease
por: Du, Hongtao, et al.
Publicado: (2023)

Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity
por: Gupta, Vijay, et al.
Publicado: (2020)

Oxidation of Methionine-35 in Alzheimer’s amyloid-beta peptide and the aggregation of the oxidized peptide
por: Friedemann, Merlin, et al.
Publicado: (2015)

Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
por: Phan, Huong T. T., et al.
Publicado: (2019)

Amyloid-beta aggregation implicates multiple pathways in Alzheimer’s disease: Understanding the mechanisms
por: Iliyasu, Musa O., et al.
Publicado: (2023)

d-Amino Acid Pseudopeptides as Potential Amyloid-Beta Aggregation Inhibitors
por: Mehrazma, Banafsheh, et al.
Publicado: (2018)

Hypochlorite-induced oxidation promotes aggregation and reduces toxicity of amyloid beta 1-42
por: Mañucat-Tan, Noralyn B., et al.
Publicado: (2023)

Familial Alzheimer’s Disease-Related Mutations Differentially Alter Stability of Amyloid-Beta Aggregates
por: Rezaei-Ghaleh, Nasrollah, et al.
Publicado: (2023)

Utility of an improved model of amyloid-beta (Aβ(1-42)) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s disease
por: McColl, Gawain, et al.
Publicado: (2012)

Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors
por: Villar-Piqué, Anna, et al.
Publicado: (2012)

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity
por: Ghanem, Simona S., et al.
Publicado: (2022)

Computational Design of New Peptide Inhibitors for Amyloid Beta (Aβ) Aggregation in Alzheimer's Disease: Application of a Novel Methodology
por: Eskici, Gözde, et al.
Publicado: (2013)

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
por: Sardar Sinha, Maitrayee, et al.
Publicado: (2018)

A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer’s disease
por: Chen, Zu-Lin, et al.
Publicado: (2023)

Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes
por: Rushworth, Jo V., et al.
Publicado: (2010)

Novel engineered nanobodies specific for N‐terminal region of alpha‐synuclein recognize Lewy‐body pathology and inhibit in‐vitro seeded aggregation and toxicity
por: Hmila, Issam, et al.
Publicado: (2022)

Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity
por: Rudolph, Stephan, et al.
Publicado: (2016)

A Systematic Screening of Traditional Chinese Medicine Identifies Two Novel Inhibitors Against the Cytotoxic Aggregation of Amyloid Beta
por: Ma, Liang, et al.
Publicado: (2021)

Crocus-derived compounds alter the aggregation pathway of Alzheimer’s Disease: associated beta amyloid protein
por: Koulakiotis, Nikolaos Stavros, et al.
Publicado: (2020)

Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer’s disease
por: Sideris, Dimitrios I, et al.
Publicado: (2021)

Natural Inhibitors of Amyloid Aggregation
por: Tortora, Paolo, et al.
Publicado: (2023)

Amyloid β-Sheet Mimics that Antagonize Amyloid Aggregation and Reduce Amyloid Toxicity
por: Cheng, Pin-Nan, et al.
Publicado: (2012)

The Major Components of Cerebrospinal Fluid Dictate the Characteristics of Inhibitors against Amyloid-Beta Aggregation
por: Sakalauskas, Andrius, et al.
Publicado: (2023)

Effect of Bacterial Amyloid Protein Phenol−Soluble Modulin Alpha 3 on the Aggregation of Amyloid Beta Protein Associated with Alzheimer’s Disease
por: Peng, Bushu, et al.
Publicado: (2023)

Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles
por: Han, Sun-Ho, et al.
Publicado: (2011)

Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance
por: Marr, Robert A., et al.
Publicado: (2014)

The Effect of Glycosaminoglycans (GAGs) on Amyloid Aggregation and Toxicity
por: Iannuzzi, Clara, et al.
Publicado: (2015)

The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
por: Porter, Tenielle, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_havopj0l48q1mdboqpudmj3ohq